ArticleHealth science reports2022

Comparison of eradication rates of moxifloxacin-rifabutin triple therapy and bismuth quadruple therapy as second-line regimens in patients with peptic ulcers.

Chang Min Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.